Covaxin Phase-3 Clinical Trials Begin in AIIMS

COVID-19 vaccine Covaxin's Phase-3 human trials began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday.

from Medindia Health News https://ift.tt/2V4UEX5